Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications (Q37050507)
Jump to navigation
Jump to search
scientific article published on January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications |
scientific article published on January 2008 |
Statements
1 reference
Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications (English)
1 reference
Yuan Cheng
1 reference
Keren Paz
1 reference
1 January 2008
1 reference
1 reference